Related references
Note: Only part of the references are listed.Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Jason D. Fontenot et al.
JOURNAL OF IMMUNOLOGY (2017)
The architectural pattern of FOXP3-positive T cells in follicular lymphoma is an independent predictor of survival and histologic transformation
Pedro Farinha et al.
BLOOD (2010)
Phase II trial of imiquimod and HPV therapeutic vaccination in patients with vulval intraepithelial neoplasia
S. Daayana et al.
BRITISH JOURNAL OF CANCER (2010)
Intratumoral CD8+ T/FOXP3+ cell ratio is a predictive marker for survival in patients with colorectal cancer
Hiroyuki Suzuki et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Immune Stimulatory Receptor CD40 Is Required for T-Cell Suppression and T Regulatory Cell Activation Mediated by Myeloid-Derived Suppressor Cells in Cancer
Ping-Ying Pan et al.
CANCER RESEARCH (2010)
Accumulation of Foxp3+ T Regulatory Cells in Draining Lymph Nodes Correlates with Disease Progression and Immune Suppression in Colorectal Cancer Patients
Liufu Deng et al.
CLINICAL CANCER RESEARCH (2010)
Two Distinct Mechanisms of Augmented Antitumor Activity by Modulation of Immunostimulatory/Inhibitory Signals
Jun Mitsui et al.
CLINICAL CANCER RESEARCH (2010)
Modulation of Lymphocyte Regulation for Cancer Therapy: A Phase II Trial of Tremelimumab in Advanced Gastric and Esophageal Adenocarcinoma
Christy Ralph et al.
CLINICAL CANCER RESEARCH (2010)
Enrichment of CCR6(+)Foxp3(+) regulatory T cells in the tumor mass correlates with impaired CD8(+) T cell function and poor prognosis of breast cancer
Lin Xu et al.
CLINICAL IMMUNOLOGY (2010)
Co-expression of TNFR2 and CD25 identifies more of the functional CD4+FOXP3+ regulatory T cells in human peripheral blood
Xin Chen et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Transforming Growth Factor-β Signaling Curbs Thymic Negative Selection Promoting Regulatory T Cell Development
Weiming Ouyang et al.
IMMUNITY (2010)
Targeted knock down of CCL22 and CCL17 by siRNA during DC differentiation and maturation affects the recruitment of T subsets
Shijun Kang et al.
IMMUNOBIOLOGY (2010)
Regulatory T cells in tumor immunity
Hiroyoshi Nishikawa et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Phase I Study of Single-Agent Anti-Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates
Julie R. Brahmer et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
LAG-3 Expression Defines a Subset of CD4+CD25highFoxp3+ Regulatory T Cells That Are Expanded at Tumor Sites
Chiara Camisaschi et al.
JOURNAL OF IMMUNOLOGY (2010)
Cutting Edge: Programmed Death-1 Defines CD8+ CD122+ T Cells as Regulatory versus Memory T Cells
Hehua Dai et al.
JOURNAL OF IMMUNOLOGY (2010)
Expression of Helios, an Ikaros Transcription Factor Family Member, Differentiates Thymic-Derived from Peripherally Induced Foxp3(+) T Regulatory Cells
Angela M. Thornton et al.
JOURNAL OF IMMUNOLOGY (2010)
Regulatory (FoxP3+) T-cell Tumor Infiltration Is a Favorable Prognostic Factor in Advanced Colon Cancer Patients Undergoing Chemo or Chemoimmunotherapy
Pierpaolo Correale et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Clinical Use of Anti-CD25 Antibody Daclizumab to Enhance Immune Responses to Tumor Antigen Vaccination by Targeting Regulatory T cells
Andrew J. Rech et al.
CANCER VACCINES (2009)
Regulatory T Cells Are Reduced During Anti-CD25 Antibody Treatment of Multiple Sclerosis
Unsong Oh et al.
ARCHIVES OF NEUROLOGY (2009)
The prognostic value of peritumoral regulatory T cells and its correlation with intratumoral cyclooxygenase-2 expression in clear cell renal cell carcinoma
Jin F. Li et al.
BJU INTERNATIONAL (2009)
Depletion of endogenous tumor-associated regulatory T cells improves the efficacy of adoptive cytotoxic T-cell immunotherapy in murine acute myeloid leukemia
Qing Zhou et al.
BLOOD (2009)
Selective expression of latency-associated peptide (LAP) and IL-1 receptor type I/II (CD121a/CD121b) on activated human FOXP3+ regulatory T cells allows for their purification from expansion cultures
Dat Q. Tran et al.
BLOOD (2009)
Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy
C. Marcela Diaz-Montero et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Tumor eradication after cyclophosphamide depends on concurrent depletion of regulatory T cells: a role for cycling TNFR2-expressing effector-suppressor T cells in limiting effective chemotherapy
Robbert G. van der Most et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Immune evasion mechanisms in colorectal cancer liver metastasis patients vaccinated with TroVax (MVA-5T4)
Eyad Elkord et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
FOXP3 Defines Regulatory T Cells in Human Tumor and Autoimmune Disease
Ilona Kryczek et al.
CANCER RESEARCH (2009)
Increased Intratumoral FOXP3-positive Regulatory Immune Cells during Interleukin-2 Treatment in Metastatic Renal Cell Carcinoma
Hanne Krogh Jensen et al.
CLINICAL CANCER RESEARCH (2009)
Membrane protein GARP is a receptor for latent TGF-β on the surface of activated human Treg
Julie Stockis et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue
N. Chaput et al.
GUT (2009)
Presence of tumor-infiltrating lymphocytes is an independent prognostic factor in type I and II endometrial cancer
R. A. de Jong et al.
GYNECOLOGIC ONCOLOGY (2009)
Natural and Adaptive Foxp3+ Regulatory T Cells: More of the Same or a Division of Labor?
Maria A. Curotto de Lafaille et al.
IMMUNITY (2009)
Mechanisms of Foxp3+ T Regulatory Cell-Mediated Suppression
Ethan M. Shevach
IMMUNITY (2009)
Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription Factor
Makoto Miyara et al.
IMMUNITY (2009)
Regulatory T cells: how do they suppress immune responses?
Shimon Sakaguchi et al.
INTERNATIONAL IMMUNOLOGY (2009)
Identification of heme oxygenase-1-specific regulatory CD8+ T cells in cancer patients
Mads Hald Andersen et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
FOXP3 Expression and Overall Survival in Breast Cancer
Andrea Merlo et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Tumor-Infiltrating FOXP3+ T Regulatory Cells Show Strong Prognostic Significance in Colorectal Cancer
Paul Salama et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Pharmacogenomic approach for the identification of novel determinants of acquired resistance to oxaliplatin in colorectal cancer
Anna Martinez-Cardus et al.
MOLECULAR CANCER THERAPEUTICS (2009)
GARP (LRRC32) is essential for the surface expression of latent TGF-β on platelets and activated FOXP3+ regulatory T cells
Dat Q. Tran et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Expression of GARP selectively identifies activated human FOXP3+regulatory T cells
Rui Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Frequency and Gene Expression Profile of Regulatory T Cells in Renal Cell Carcinoma
Andreas Jeron et al.
TUMOR BIOLOGY (2009)
Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
CTLA4 blockade expands FoxP3+ regulatory and activated effector CD4+ T cells in a dose-dependent fashion
Brian Kavanagh et al.
BLOOD (2008)
Clinical and immunologic results of a phase II trial of sequential imiquimod and photodynamic therapy for vulval intraepithelial neoplasia
Ursula Winters et al.
CLINICAL CANCER RESEARCH (2008)
Regulatory T cells and treatment of cancer
Tyler J. Curiel
CURRENT OPINION IN IMMUNOLOGY (2008)
Intratumoural FOXP3-positive regulatory T cells are associated with adverse prognosis in radically resected gastric cancer
Giuseppe Perrone et al.
EUROPEAN JOURNAL OF CANCER (2008)
A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4+CD25+Foxp3+ T cells
Bastian Hoechst et al.
GASTROENTEROLOGY (2008)
Two functional subsets of FOXP3+ regulatory T cells in human thymus and periphery
Tomoki Ito et al.
IMMUNITY (2008)
Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells
Ilaria Marigo et al.
IMMUNOLOGICAL REVIEWS (2008)
CCL17 and CCL22 chemokines within tumor microenvironment are related to accumulation of Foxp3+ regulatory T cells in gastric cancer
Yoshiki Mizukami et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
The anticancer immune response: indispensable for therapeutic success?
Laurence Zitvogel et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
OX40 triggering blocks suppression by regulatory T cells and facilitates tumor rejection
Silvia Piconese et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Latency-associated peptide identifies a novel CD4+CD25+ regulatory T cell subset with TGFβ-mediated function and enhanced suppression of experimental autoimmune encephalomyelitis
Mei-Ling Chen et al.
JOURNAL OF IMMUNOLOGY (2008)
Expression of ICOS on human melanoma-infiltrating CD4+CD25highFoxp3+ T regulatory cells:: Implications and impact on tumor-mediated immune suppression
Laura Strauss et al.
JOURNAL OF IMMUNOLOGY (2008)
Expression of TNFR2 defines a maximally suppressive subset of mouse CD4+CD25+FoxP3+ T regulatory cells:: Applicability to tumor-infiltrating T regulatory cells
Xin Chen et al.
JOURNAL OF IMMUNOLOGY (2008)
The Foxp3(+) regulatory T cell: a jack of all trades, master of regulation
Qizhi Tang et al.
NATURE IMMUNOLOGY (2008)
Immunoregulatory T Cells: Role and Potential as a Target in Malignancy
Marc Beyer et al.
CURRENT ONCOLOGY REPORTS (2008)
CD4+ T-cell recognition of human 5T4 oncofoetal antigen:: implications for initial depletion of CD25+ T cells
Eyad Elkord et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Adoptive transfer of Treg depleted autologous T cells in advanced renal cell carcinoma
Fiona C. Thistlethwaite et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Circulating tumor antigen-specific regulatory T cells in patients with metastatic melanoma
Luis Vence et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
IL-2 immunotoxin denileukin diftitox reduces regulatory T cells and enhances vaccine-mediated T-cell immunity
Mary T. Litzinger et al.
BLOOD (2007)
Frequency of regulatory T cells in renal cell carcinoma patients and investigation of correlation with survival
Richard W. Griffiths et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Regulatory T-cell inhibition versus depletion: the right choice in cancer immunotherapy
Mario P. Colombo et al.
NATURE REVIEWS CANCER (2007)
Induction of FOXP3 expression in naive human CD4+FOXP3- T cells by T-cell receptor stimulation is transforming growth factor-β-dependent but does not confer a regulatory phenotype
Dat Q. Tran et al.
BLOOD (2007)
Administration of a CD25-directed immunotoxin, LMB-2, to patients with metastatic melanoma induces a selective partial reduction in regulatory T cells in vivo
Daniel J. Powell et al.
JOURNAL OF IMMUNOLOGY (2007)
Pathways mediating the expansion and immunosuppressive activity of myeloid-derived suppressor cells and their relevance to cancer therapy
James E. Talmadge
CLINICAL CANCER RESEARCH (2007)
Expansion of human T regulatory type 1 cells in the microenvironment of cyclooxygenase 2 overexpressing head and neck squamous cell carcinoma
Christoph Bergmann et al.
CANCER RESEARCH (2007)
Control of immune responses by antigen-specific regulatory T cells expressing the folate receptor
Tomoyuki Yamaguchi et al.
IMMUNITY (2007)
Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection
Qiang Gao et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Depletion of CD4+CD25+ human regulatory T cells in vivo:: Kinetics of Treg depletion and alterations in immune functions in vivo and in vitro
Karsten Mahnke et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients
Junliang Fu et al.
GASTROENTEROLOGY (2007)
Inability to mediate prolonged reduction of regulatory T cells after transfer of autologous CD25-depleted PBMC and interleukin-2 after lymphodepleting chemotherapy
Daniel J. Powell et al.
JOURNAL OF IMMUNOTHERAPY (2007)
Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25- into CD25+ T regulatory cells
Antonio Curti et al.
BLOOD (2007)
Natural regulatory T cells and de novo-induced regulatory T cells contribute independently to tumor-specific tolerance
Gang Zhou et al.
JOURNAL OF IMMUNOLOGY (2007)
Transient expression of FOXP3 in human activated nonregulatory CD4(+) T cells
Jun Wang et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
Vaccination against the forkhead family transcription factor Foxp3 enhances tumor immunity
Smita Nair et al.
CANCER RESEARCH (2007)
Regulatory T cells and cancer
Helen Y. Wang et al.
CURRENT OPINION IN IMMUNOLOGY (2007)
CD4 regulatory T cells in human cancer pathogenesis
Keith L. Knutson et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
CD4+ CD25+ FOXP3+ Regulatory T Cells Suppress Anti-Tumor Immune Responses in Patients with Colorectal Cancer
Sarah L. Clarke et al.
PLOS ONE (2006)
In situ analysis of FOXP3+ regulatory T cells in human colorectal cancer
Christoph Loddenkemper et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2006)
Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse
Gaynor J. Bates et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma
Joaquim Carreras et al.
BLOOD (2006)
Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinorna and its premalignant lesions
Nobuyoshi Hiraoka et al.
CLINICAL CANCER RESEARCH (2006)
Foxp3-dependent and -independent molecules specific for CD25+CD4+ natural regulatory T cells revealed by DNA microarray analysis
Naoshi Sugimoto et al.
INTERNATIONAL IMMUNOLOGY (2006)
The GITR-GITRL interaction: co-stimulation or contrasuppression of regulatory activity?
Ethan M. Shevach et al.
NATURE REVIEWS IMMUNOLOGY (2006)
CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells
Weihong Liu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells
Nabila Seddiki et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Tumor-infiltrating cytotoxic T cells but not regulatory T cells predict outcome in anal squamous cell carcinoma
Gerhard G. Grabenbauer et al.
CLINICAL CANCER RESEARCH (2006)
Intra-tumoural regulatory T cells: A potential new target in cancer immunotherapy
DJ Needham et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Toll-like receptor 2 signaling modulates the functions of CD4+CD25+ regulatory T cells
HY Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Agonist anti-GITR antibody enhances vaccine-induced CD8+ T-cell responses and tumor immunity
AD Cohen et al.
CANCER RESEARCH (2006)
Tumor-induced expansion of regulatory T cells by conversion of CD4+CD25- lymphocytes is thymus and proliferation independent
B Valzasina et al.
CANCER RESEARCH (2006)
Regulatory T cells, tumour immunity and immunotherapy
WP Zou
NATURE REVIEWS IMMUNOLOGY (2006)
Regulated compartmentalization of programmed cell death-1 discriminates CD4+CD25+ resting regulatory T cells from activated T cells
Giorgio Raimondi et al.
JOURNAL OF IMMUNOLOGY (2006)
Characterization of CD4+CD25+ regulatory T cells in patients treated with high-dose interleukin-2 for metastatic melanoma or renal cell carcinoma
GC Cesana et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Amplification of tumor-specific regulatory T cells following therapeutic cancer vaccines
G Zhou et al.
BLOOD (2006)
Effect of CD4+CD25+ and CD4+CD25- T regulatory cells on the generation of cytolytic T cell response to a self but human tumor-associated epitope in vitro
S Chattopadhyay et al.
JOURNAL OF IMMUNOLOGY (2006)
Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
E Sato et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer
D Wolf et al.
CLINICAL CANCER RESEARCH (2005)
Analysis of the cellular mechanism of antitumor responses and autoimmunity in patients treated with CTLA-4 blockade
AV Maker et al.
JOURNAL OF IMMUNOLOGY (2005)
Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells
J Dannull et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
The IL-4 receptor α-chain-binding cytokines, IL-4 and IL-13, induce forkhead box P3-expressing CD25+CD4+ regulatory T cells from CD25-CD4+ precursors
A Skapenko et al.
JOURNAL OF IMMUNOLOGY (2005)
Inability of a fusion protein of IL-2 and diphtheria toxin (Denileukin Diftitox, DAB389IL-2, ONTAK) to eliminate regulatory T lymphocytes in patients with melanoma
P Attia et al.
JOURNAL OF IMMUNOTHERAPY (2005)
Continuous control of autoimmune disease by antigen-dependent polyclonal CD4+ CD25+ regulatory T cells in the regional lymph node
ET Samy et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Reduced frequencies and suppressive function of CD4+CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine
M Beyer et al.
BLOOD (2005)
CD4+ CD25+ regulatory T cells control the induction of antigen-specific CD4+ helper T cell responses in cancer patients
H Nishikawa et al.
BLOOD (2005)
Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: A mechanism of tumor evasion
AH Zea et al.
CANCER RESEARCH (2005)
Recruitment of Foxp3+ T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor
I Lee et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Immunosuppressive networks in the tumour environment and their therapeutic relevance
WP Zou
NATURE REVIEWS CANCER (2005)
Inhibition of CD4+25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide
MEC Lutsiak et al.
BLOOD (2005)
Recognition of a new ARTC1 peptide ligand uniquely expressed in tumor cells by antigen-specific CD4+ regulatory T cells
HY Wang et al.
JOURNAL OF IMMUNOLOGY (2005)
Functional characterization of EBV-encoded nuclear antigen 1-specific CD4+ helper and regulatory T cells elicited by in vitro peptide stimulation
KS Voo et al.
CANCER RESEARCH (2005)
CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative
F Ghiringhelli et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species
S Kusmartsev et al.
JOURNAL OF IMMUNOLOGY (2004)
Induction of a CD4+ T regulatory type 1 response by cyclooxygenase-2-overexpressing glioma
Y Akasaki et al.
JOURNAL OF IMMUNOLOGY (2004)
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
TJ Curiel et al.
NATURE MEDICINE (2004)
CD4+CD25+ T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion
AE Herman et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes
KV Tarbell et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Tumor-specific human CD4(+) regulatory T cells and their ligands: Implications for immunotherapy
HY Wang et al.
IMMUNITY (2004)
Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3
WJ Chen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Overproduction of vascular endothelial growth factor related to von Hippel-Lindau tumor suppressor gene mutations and hypoxia-inducible factor-1α expression in renal cell carcinomas
X Na et al.
JOURNAL OF UROLOGY (2003)
Renal cell carcinoma induces prostaglandin E2 and T-helper type 2 cytokine production in peripheral blood mononuclear cells
GP Smyth et al.
ANNALS OF SURGICAL ONCOLOGY (2003)
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
JD Fontenot et al.
NATURE IMMUNOLOGY (2003)
Control of regulatory T cell development by the transcription factor Foxp3
S Hori et al.
SCIENCE (2003)
Naturally arising CD25+CD4+ regulatory T cells in maintaining immunologic self-tolerance and preventing autoimmune disease
T Takahashi et al.
CURRENT MOLECULAR MEDICINE (2003)
Cancer immunoediting: from immunosurveillance to tumor escape
GP Dunn et al.
NATURE IMMUNOLOGY (2002)
Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4+CD25+ regulatory T cells
A Iellem et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Induction and mechanism of action of transforming growth factor-β-secreting Th3 regulatory cells
HL Weiner
IMMUNOLOGICAL REVIEWS (2001)
ICOS co-stimulatory receptor is essential for T-cell activation and function
C Dong et al.
NATURE (2001)
Share Paper
